Manufacturing

Oct 15, 2016
BioPharm International
Designing systems using the principles of good documentation practice, including validated audit trails, is a key piece of a manufacturing data integrity program.
Oct 15, 2016
BioPharm International
BioPharm International spoke with Selexis CEO and Chairman Igor Fisch, PhD about the latest cell-line development advances.
Oct 14, 2016
By BioPharm International Editors
The companies will collaborate on the manufacture of personalized cancer vaccines.
Oct 11, 2016
By BioPharm International Editors
HHS entered into a contract with BioProtection Systems Corp. for commercial manufacturing tests of an Ebola vaccine.
Oct 07, 2016
By BioPharm International Editors
WuXi AppTec’s new biomanufacturing facility is its third facility in the Philadelphia, PA Navy Yard.
Oct 06, 2016
By BioPharm International Editors
A report from the European Union Intellectual Property Office shows that the EU loses approximately €10.2 billion a year due to counterfeit medicines.
Oct 06, 2016
By BioPharm International Editors
The companies are collaborating on the commercialization of two biosimilar candidates in the US and Canada.
Oct 06, 2016
Results from the Phase III POLLUX trial with Janssen’s Darzalex showed that the drug was effective at reducing disease progression in patients with relapsed or refractory multiple myeloma.
Oct 05, 2016
By BioPharm International Editors
Constantia Flexibles acquired a flexible packaging business from Lamp San Prospero SPA.
Oct 05, 2016
By BioPharm International Editors
The company announced that it will build a new manufacturing facility at the GMR Aerospace Park at the Rajiv Gandhi International Airport in India.
native1_300x100
lorem ipsum